Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hyoscine methylbromide |
Is a |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing methscopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochlorid 8mg/2.5mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methscopolamine nitrate + pseudoephedrine hydrochlorid 2.5mg/120mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methscopolamine m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing methscopolamine and pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely methscopolamine 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methscopolamine nitrate (substance) |
Is a |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely methscopolamine 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methscopolamine 5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine nitrate + pseudoephedrine hydrochlorid 2.5mg/120mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine nitrate + pseudoephedrine hydrochlorid 2.5mg/120mg tablet (product) |
Has basis of strength substance (attribute) |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine nitrate (substance) |
Is modification of (attribute) |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscine methylbromide |
Is modification of (attribute) |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely methscopolamine 5 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine nitrate + pseudoephedrine hydrochlorid 2.5mg/120mg tablet (product) |
Has precise active ingredient |
False |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only methscopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorphenamine- and methscopolamine- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorphenamine and methscopolamine and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing chlorphenamine and methscopolamine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methscopolamine nitrate + pseudoephedrine hydrochlorid 2.5mg/120mg tablet (product) |
Has precise active ingredient |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Methscopolamine nitrate + pseudoephedrine hydrochlorid 2.5mg/120mg tablet (product) |
Has basis of strength substance (attribute) |
True |
Methscopolamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |